0
Chemotherapy is a conventional oncology treatment or care pathway used within standard cancer care, usually under the direction of oncology specialists and with disease-specific i...
Chemotherapy
Introduction
Chemotherapy is tracked in this database as a conventional oncology treatment or care pathway. It appears in cancer-related discussions because patients, clinicians, authors, clinics, researchers, or alternative-health communities have connected it with cancer prevention, active treatment, treatment support, symptom relief, recovery, or survivorship. The purpose of this entry is to describe what the protocol is, how it is usually framed, and what kind of caution belongs around it.
This entry is not a recommendation to use the protocol. It is a structured research note so that books, articles, videos, organizations, individuals, and related diseases can be connected in one place.
How It Connects With Cancer
Chemotherapy is used within standard cancer care, usually under the direction of oncology specialists and with disease-specific indications. Some sources discuss it as a direct anticancer strategy, while others frame it as supportive care, quality-of-life care, nutrition support, symptom management, rehabilitation, or a way to improve resilience during conventional treatment.
The practical question is not simply whether the topic is "good" or "bad." The important questions are what cancer setting it is being discussed for, whether it is meant to replace or accompany conventional oncology, what evidence supports the claim, what risks or interactions exist, and whether the patient can be monitored appropriately.
Evidence and Controversy
Its evidence posture depends on the exact cancer type, stage, line of therapy, and whether the treatment is being used according to approved or guideline-supported indications. Strong claims about curing cancer, shrinking tumors, detoxifying the body, repairing DNA, activating immunity, or replacing standard treatment should be separated from more modest claims such as improving comfort, nutrition, sleep, mood, function, or treatment tolerance.
For research review, this protocol should be connected to both supportive and critical sources when available. Positive reports, practitioner experience, case histories, mechanistic papers, clinical trials, safety warnings, regulatory actions, and skeptical reviews can all be useful, as long as they are clearly labeled and not treated as equal levels of evidence.
Safety and Practical Considerations
Risks can include treatment-specific side effects, drug interactions, procedure complications, blood-count changes, organ stress, or recovery issues that require clinical monitoring. Cancer patients may have special vulnerabilities, including immune suppression, bleeding risk, bowel obstruction, cachexia, organ impairment, implanted devices, neuropathy, surgical wounds, drug interactions, or rapidly changing disease status.
Before using this protocol in a real care plan, patients should review it with clinicians who understand their diagnosis, stage, pathology, current treatment, medications, lab results, and goals of care. This is especially important when a protocol involves ingesting substances, injections, devices, fasting, detoxification, heat, electrical current, intense breathwork, or abandoning established treatment.
WooWoo Scale Placement
This protocol is currently placed at 0 / 10 on the database scale: Conventional. The score is intended as an organizational signal, not a moral judgment. It helps separate conventional oncology, recognized integrative care, diet and supplement approaches, functional or independent methods, alternative systems, experimental approaches, unapproved therapies, technical healing methods, and spiritual or distance-healing claims.
Types of Chemo used with Stomach Cancer
Chemotherapy drugs or named regimens currently linked to Stomach Cancer in the Chemo database are listed alphabetically. Actual use depends on stage, tumor biology, biomarkers, prior treatment, organ function, performance status, and the treating oncology team.
Capecitabine
Short Description
Capecitabine is a oral fluoropyrimidine antimetabolite prodrug used as anticancer chemotherapy. Capecitabine is an anticancer chemotherapy or oncology drug option. It is recorded as oral fluoropyrimidine antimetabolite prodrug. Typical application: Oral tablets. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Oral fluoropyrimidine used in breast and GI cancers and as a substitute for infusional fluorouracil in some regimens. Use varies by disease setting and should be checked against current oncology guidelines.
Sourcehttps://www.cancer.gov/about-cancer/treatment/drugs/cancer-drugs
CAPOX
Short Description
CAPOX is a chemotherapy combination regimen. CAPOX is an anticancer chemotherapy or oncology drug option. It is recorded as Combination regimen: capecitabine and oxaliplatin. Typical application: Combination regimen; route and cycle schedule depend on protocol.. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Also called XELOX; common colorectal and GI regimen. Specific use depends on diagnosis, stage, fitness, prior therapy, and current guideline status.
Sourcehttps://www.cancer.gov/about-cancer/treatment/drugs/capox
Carboplatin-Paclitaxel
Short Description
Carboplatin-Paclitaxel is a chemotherapy combination regimen. Carboplatin-Paclitaxel is an anticancer chemotherapy or oncology drug option. It is recorded as Combination regimen: carboplatin and paclitaxel. Typical application: Combination regimen; route and cycle schedule depend on protocol.. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Very common platinum-taxane regimen across gynecologic and thoracic cancers and selected squamous cancers. Specific use depends on diagnosis, stage, fitness, prior therapy, and current guideline status.
Sourcehttps://www.cancer.gov/about-cancer/treatment/drugs/carboplatin-taxol
Cisplatin
Short Description
Cisplatin is a platinum compound used as anticancer chemotherapy. Cisplatin is an anticancer chemotherapy or oncology drug option. It is recorded as platinum compound. Typical application: IV infusion. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Core platinum chemotherapy used in many solid tumor and germ-cell regimens. Use varies by disease setting and should be checked against current oncology guidelines.
Sourcehttps://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/types-of-chemo-drugs.html
Cisplatin-5-FU
Short Description
Cisplatin-5-FU is a chemotherapy combination regimen. Cisplatin-5-FU is an anticancer chemotherapy or oncology drug option. It is recorded as Combination regimen: cisplatin and fluorouracil. Typical application: Combination regimen; route and cycle schedule depend on protocol.. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Classic platinum/fluoropyrimidine regimen used in head and neck and upper GI cancers; also used in selected squamous cancers. Specific use depends on diagnosis, stage, fitness, prior therapy, and current guideline status.
Sourcehttps://www.cancer.gov/about-cancer/treatment/drugs/cancer-drugs
DCF
Short Description
DCF is a chemotherapy combination regimen. DCF is an anticancer chemotherapy or oncology drug option. It is recorded as Combination regimen: docetaxel, cisplatin, and fluorouracil. Typical application: Combination regimen; route and cycle schedule depend on protocol.. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Upper-GI and head/neck chemotherapy regimen; modified versions are more common in some settings. Specific use depends on diagnosis, stage, fitness, prior therapy, and current guideline status.
Sourcehttps://www.cancer.gov/about-cancer/treatment/drugs/cancer-drugs
Docetaxel
Short Description
Docetaxel is a taxane microtubule inhibitor used as anticancer chemotherapy. Docetaxel is an anticancer chemotherapy or oncology drug option. It is recorded as taxane microtubule inhibitor. Typical application: IV infusion. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Taxane used across breast, prostate, lung, gastric, head and neck, and other solid tumors. Use varies by disease setting and should be checked against current oncology guidelines.
Sourcehttps://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/types-of-chemo-drugs.html
ECF
Short Description
ECF is a chemotherapy combination regimen. ECF is an anticancer chemotherapy or oncology drug option. It is recorded as Combination regimen: epirubicin, cisplatin, and fluorouracil. Typical application: Combination regimen; route and cycle schedule depend on protocol.. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Older or less commonly used; current role may be limited by newer regimens, toxicity, biomarkers, or supportive-care standards.
Older upper-GI regimen largely supplanted by newer approaches in many settings. Specific use depends on diagnosis, stage, fitness, prior therapy, and current guideline status.
Sourcehttps://www.cancer.gov/about-cancer/treatment/drugs/cancer-drugs
ECX
Short Description
ECX is a chemotherapy combination regimen. ECX is an anticancer chemotherapy or oncology drug option. It is recorded as Combination regimen: epirubicin, cisplatin, and capecitabine. Typical application: Combination regimen; route and cycle schedule depend on protocol.. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Older or less commonly used; current role may be limited by newer regimens, toxicity, biomarkers, or supportive-care standards.
Older upper-GI regimen using oral capecitabine instead of fluorouracil. Specific use depends on diagnosis, stage, fitness, prior therapy, and current guideline status.
Sourcehttps://www.cancer.gov/about-cancer/treatment/drugs/cancer-drugs
Epirubicin
Short Description
Epirubicin is a anthracycline antitumor antibiotic used as anticancer chemotherapy. Epirubicin is an anticancer chemotherapy or oncology drug option. It is recorded as anthracycline antitumor antibiotic. Typical application: IV infusion. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Used in breast cancer and historical upper-GI regimens such as ECF/ECX. Use varies by disease setting and should be checked against current oncology guidelines.
Sourcehttps://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/types-of-chemo-drugs.html
FLOT
Short Description
FLOT is a chemotherapy combination regimen. FLOT is an anticancer chemotherapy or oncology drug option. It is recorded as Combination regimen: fluorouracil, leucovorin, oxaliplatin, and docetaxel. Typical application: Combination regimen; route and cycle schedule depend on protocol.. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Perioperative regimen for selected gastric and gastroesophageal junction adenocarcinomas. Specific use depends on diagnosis, stage, fitness, prior therapy, and current guideline status.
Sourcehttps://www.cancer.gov/about-cancer/treatment/drugs/cancer-drugs
Fluorouracil
Short Description
Fluorouracil is a fluoropyrimidine antimetabolite used as anticancer chemotherapy. Fluorouracil is an anticancer chemotherapy or oncology drug option. It is recorded as fluoropyrimidine antimetabolite. Typical application: IV infusion or bolus. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Core chemotherapy drug for colorectal, anal, breast, upper GI, pancreatic, biliary, and head and neck cancers. Use varies by disease setting and should be checked against current oncology guidelines.
Sourcehttps://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/types-of-chemo-drugs.html
FOLFIRI
Short Description
FOLFIRI is a chemotherapy combination regimen. FOLFIRI is an anticancer chemotherapy or oncology drug option. It is recorded as Combination regimen: leucovorin, fluorouracil, and irinotecan. Typical application: Combination regimen; route and cycle schedule depend on protocol.. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Common colorectal regimen and used in selected upper-GI contexts. Specific use depends on diagnosis, stage, fitness, prior therapy, and current guideline status.
Sourcehttps://www.cancer.gov/about-cancer/treatment/drugs/folfiri
FOLFOX
Short Description
FOLFOX is a chemotherapy combination regimen. FOLFOX is an anticancer chemotherapy or oncology drug option. It is recorded as Combination regimen: leucovorin, fluorouracil, and oxaliplatin. Typical application: Combination regimen; route and cycle schedule depend on protocol.. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Common colorectal and GI regimen. Specific use depends on diagnosis, stage, fitness, prior therapy, and current guideline status.
Sourcehttps://www.cancer.gov/about-cancer/treatment/drugs/folfox
Irinotecan
Short Description
Irinotecan is a topoisomerase I inhibitor used as anticancer chemotherapy. Irinotecan is an anticancer chemotherapy or oncology drug option. It is recorded as topoisomerase I inhibitor. Typical application: IV infusion. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Used in colorectal cancer and selected GI, pancreatic, lung, and cervical cancer regimens. Use varies by disease setting and should be checked against current oncology guidelines.
Sourcehttps://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/types-of-chemo-drugs.html
Mitomycin
Short Description
Mitomycin is a antitumor antibiotic / bioreductive alkylating agent used as anticancer chemotherapy. Mitomycin is cataloged here as an individual chemotherapy drug. It may be used alone or as part of combination regimens depending on cancer type, stage, biomarkers, prior treatment, organ function, and treatment goal.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Used with fluoropyrimidines in anal cancer and intravesically in bladder cancer; older GI/breast/head-neck uses retained. Use varies by disease setting and should be checked against current oncology guidelines.
Sourcehttps://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/types-of-chemo-drugs.html
Oxaliplatin
Short Description
Oxaliplatin is a platinum compound used as anticancer chemotherapy. Oxaliplatin is an anticancer chemotherapy or oncology drug option. It is recorded as platinum compound. Typical application: IV infusion. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Key platinum in FOLFOX, CAPOX, FOLFIRINOX, and other GI regimens. Use varies by disease setting and should be checked against current oncology guidelines.
Sourcehttps://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/types-of-chemo-drugs.html
Paclitaxel
Short Description
Paclitaxel is a taxane microtubule inhibitor used as anticancer chemotherapy. Paclitaxel is an anticancer chemotherapy or oncology drug option. It is recorded as taxane microtubule inhibitor. Typical application: IV infusion. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Common taxane used across breast, ovarian, lung, gynecologic, upper GI, head and neck, bladder, and Kaposi sarcoma settings. Use varies by disease setting and should be checked against current oncology guidelines.
Sourcehttps://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/types-of-chemo-drugs.html
Platinum-Taxane
Short Description
Platinum-Taxane is a chemotherapy combination regimen. Platinum-Taxane is an anticancer chemotherapy or oncology drug option. It is recorded as Combination regimen: cisplatin or carboplatin with paclitaxel or docetaxel. Typical application: Combination regimen; route and cycle schedule depend on protocol.. Review cancer indication, treatment line, expected benefit, side effects, interactions, monitoring needs, and fit with the patient?s oncology plan.
Effectiveness
Recognized chemotherapy option or regimen family; effectiveness depends on stage, biology, prior therapy, and patient fitness.
Common platinum/taxane regimen family across thoracic, gynecologic, upper-GI, head-neck, and urothelial cancers. Specific use depends on diagnosis, stage, fitness, prior therapy, and current guideline status.
Sourcehttps://www.cancer.gov/about-cancer/treatment/drugs/cancer-drugs